Glancy prongay & murray llp, a leading securities fraud law firm, continues investigation of regeneron pharmaceuticals, inc. (regn) on behalf of investors

Los angeles, dec. 04, 2024 (globe newswire) -- glancy prongay & murray llp (“gpm”), a leading national shareholder rights law firm, continues its investigation on behalf of regeneron pharmaceuticals, inc. (“regeneron” or the “company”) (nasdaq: regn) investors concerning the company's possible violations of the federal securities laws.
REGN Ratings Summary
REGN Quant Ranking